bioAffinity Technologies (BIAFW) Net Income
Price: $2
Market Cap: $26.98M
Avg Volume: -
Market Cap: $26.98M
Avg Volume: -
Country: US
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Sector: Healthcare
What is bioAffinity Technologies's Net Income?
- bioAffinity Technologies's annual net income as of FY 2023 is $-7.94M.
- bioAffinity Technologies's quarterly net income as of Q2 2024 is $-2.11M.
What is Net Income?
Net income is the total profit of a company after all expenses and taxes have been deducted from revenue. It is also known as net profit or net earnings and is a key indicator of a company's financial performance and profitability.
Related Metrics
Other important metrics to assess bioAffinity Technologies's financial health include:
- Net Income Growth - the rate at which a company's net income is growing:
- Annual Growth: 2.66%
- Net Income Ratio - net income divided by revenue:
- Annual: -313.41%
- Quarterly: -88.01%
- Net Income Per Share - net income divided by the number of shares outstanding:
- Annual: $-0.91
These metrics provide insights into bioAffinity Technologies's financial health and its profitability. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual Net Income
$-7.94M
Quarterly Net Income
$-2.11M
Historical Annual Net Income
Historical Quarterly Net Income
Annual Net Income Growth
Annual Net Income Per Share
bioAffinity Technologies Historical Net Income Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2023.
| Year | Net Income | Net Income Growth | Net Income Ratio | Net Income Per Share |
|---|---|---|---|---|
| 2023 | $-7.94M | 2.66% | -313.41% | $-0.91 |
| 2022 | $-8.15M | -28.89% | -169771.25% | $-1.81 |
| 2021 | $-6.33M | 12.96% | 0.00% | $-0.86 |
| 2020 | $-7.27M | -119.77% | 0.00% | $-0.99 |
| 2019 | $-3.31M | 0.00% | 0.00% | $-0.45 |